Comparison of standard mammography with digital mammography and digital infrared thermal imaging for breast cancer screening Breast cancer is the most common malignancy in women. Screenfilm mammography (SFM) has been considered the gold standard for breast cancer screening and detection. Despite its recognized value in detecting and characterizing breast disease, mammography has important limitations and its false-negative rate ranges from 4% to 34%. Given these limitations, development of imaging modalities that would enhance, complement, or replace mammography has been a priority. Digital mammography (FFDM) and digital infrared thermal imaging (DITI) are some of these alternative modalities. (J Turkish-German Gynecol Assoc 2010; 11: 152-7) Key words: Mammography, digital mammography, digital infrared thermal imaging, breast cancer Received: 9 June, 2010 Accepted: 6 August, 2010
Meme kanseri taramas nda standart mamografi ile dijital mamografi ve dijital infrared termal görüntülemenin kar la t r lmasMeme kanseri kad nlarda görülen en yayg n malignitedir. Mamografi hem tarama hem de saptama bak m ndan alt n standartt r. meme kanserindeki bu de erine ra men mamografide önemli k s tlamalar mevcuttur ve yanl negatiflik oran %4-34 aras nda de i mektedir.
Abstract ÖzetReview 152
IntroductionBreast cancer is the most common malignancy and the second most common cause of cancer death in women in the US (1). According to the American Cancer Society report on cancer facts, it accounts for about 30% of all cancers in women. Approximately one in every eight women is diagnosed with breast cancer by the age of 90, with an absolute lifetime risk of 14.4% (2). In Turkey, the ratio of breast cancer is 24.1%, ranking first of all the cancers in women (3). The incidence of breast cancer has increased, and the estimated number of breast cancer cases was 44,253 in 2007 (4, 5). There is a geographical heterogeneity regarding breast cancer incidence and survival rates in Turkey. The incidence in Western Turkey (50/100,000 in 2000) is more than twice that of the Eastern part (20/100,000) (5-7). Five year survival rates for breast cancer are 85% in Western and 60% in Eastern Turkey (7). Breast cancer survival depends upon its earliest possible detection because survival rate increases with earlier detection with a possibility of complete cure. Breast cancer has a ten year survival rate for Stage 0of 95%; Stage I, 88%; Stage II, 66%; Stage III, 36%; and stage IV, 7% (8). Larger tumor size at diagnosis is also associated with decreased survival (9). Screening might produce greater benefits for early detection if it were more sensitive and specific. A wide variety of new technologies, including alternative imaging modalities, and improvements in x-ray mammography, are being investigated with the aim of improving early-detection rates. Many imaging modalities can be used for breast screening, such as X-ray; ultrasonography, magnetic resonance imaging (MRI); computed tomography (CT); ultrasound; positron emission tomography (PET) scan...